What were the results of the SYNTAX trial comparing CABG and DES implantation?
The SYNTAX trial randomly assigned 1800 patients (of a total of 4337 who were screened) to receive DES or CABG. Major adverse cardiac events (MACE), a composite of death, stroke, MI, or repeat revascularization during the 3 years after randomization, occurred in 20.2% of CABG patients and 28.0% of those undergoing DES implantation (P 0.001).